Patient-centred healthcare is here to stay, so how can pharma sales embrace it?
Our Mobile Health is on a mission to build confidence in digital health by assessing and curating high-quality health apps. CEO Julie Bretland tells us what the company looks for in a good app and how digital health can change the industry
Feat.: Making health apps a reality; Brexit and the supply chain; Patiet-centric sales
Why medical affairs is the most important role in the future of pharma
The myriad ways digital tools could change everything for pharma and the NHS
The prestigious PharmaTimes Marketer of the Year competition closes for entries on 1 September. It only takes a few seconds to fill out the online entry form and then you don’t need to do anything else until the day of the competition. This year is extra special as the competition is celebrating its 25th anniversary - and we don't want you to miss out.
US regulators have further expanded the scope of Bristol Myers Squibb’s Opdivo, approving its use for a previously treated small cell lung cancer.
20th August 2018
Cost regulators for the NHS in England and Wales have not approved funding for TiGenix and Takeda’s Alofisel - the first allogeneic stem cell therapy to be approved for use across the European Union – for use in Crohn’s patients in draft guidelines.
20th August 2018
The number of children and young people being treated for type II diabetes has leapt by around 40 percent in just four years to more than 700 cases, NHS data show.
20th August 2018
Confusion about cancer symptoms among workers could be leading to delayed diagnoses and irregular self-examinations, suggests new research by Bupa UK.
20th August 2018
The PharmaTimes Sales Awards closes for entry in just a few weeks and with Sanofi, Allergan, LEO Pharma, Novartis and Bio Products Laboratory and many more besides signed up to take part, all signs are pointing to a very exciting debut indeed. It only takes a few seconds to fill out the online entry form and entrants need not do anything else until the day of the competition.
17th August 2018
There is still much to do to realise the full cost saving benefits of biosimilars, and much of this boils down to clinical confidence
A growing body of evidence suggests that two-drug regimens could be hugely important for HIV patients
Patient-centricity, biotech and new data tech have all characterised a record H1 for pharma deals
CRISPR could help turn Alzhimer's findings into a cure, but there are several barriers to overcome first
Katie Ruane was just 22 when diagnosed with CML, and while drugs keep the disease in remission it still takes a huge toll on her life
NHS England’s assurance process provides a window of opportunity for pharma – but communication and joint working with the health service is key
The failure of several Alzheimer’s drug trials in the past year has dampened, but not destroyed, hopes for a cure
Home DNA tests are now common, but using genome sequencing to personalise drugs still has some way to go
The regulatory impacts of Brexit could be far-reaching, so now is not the time to take a ‘wait and see’ approach
The myriad ways digital tools could change everything for pharma and the NHS
Our Mobile Health is on a mission to build confidence in digital health by assessing and curating high-quality health apps. CEO Julie Bretland tells us what the company looks for in a good app and how digital health can change the industry
Patient-centred healthcare is here to stay, so how can pharma sales embrace it?
Why patient centricity throughout the lifecycle is not a fad, sales tactic or trend
Simon Grime, director of Fendix, explains how pharma can utilise its wealth of existing resources and content to improve collaboration with the NHS online
Peter Cherry, PhD, Medmeme’s vice president, information systems, explores how pharma can identify predatory journals and conferences
The importance of a patient-centric focus to improve the real-world use of medicine was extensively discussed during the 3rd Annual Patient Engagement and Experience Conference (16–17th May 2018, Amsterdam, Netherlands).
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
